Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Receptor Interacting Serine/Threonine Kinase 1 (RIPK1)-media...
| Class:Id | Summation:9693923 |
|---|---|
| _displayName | Receptor Interacting Serine/Threonine Kinase 1 (RIPK1)-media... |
| _timestamp | 2020-08-20 15:48:21 |
| created | [InstanceEdit:9693932] Shamovsky, Veronica, 2020-07-08 |
| literatureReference | [LiteratureReference:9693924] Necroptosis in development and diseases |
| modified | [InstanceEdit:9697786] Shamovsky, Veronica, 2020-08-20 |
| text | Receptor Interacting Serine/Threonine Kinase 1 (RIPK1)-mediated regulated necrosis also called necroptosis is an important type of programmed cell death in addition to apoptosis. Necroptosis eventually leads to cell lysis and release of cytoplasmic content into the extracellular region. Necroptosis must be tightly controlled. Disregulated or defective necroptotic cell death is often associated with a tissue damage resulting in an intense inflammatory response. Defects of necroptosis may contribute to various pathological processes, including autoimmune disease, neurodegeneration, multiple cancers, and kidney injury. |
| (summation) | [Pathway:9693928] Defective RIPK1-mediated regulated necrosis [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Receptor Interacting Serine/Threonine Kinase 1 (RIPK1)-media... (9693923)
